UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 101

Sortiert nach

Emergence of multidrug resistance among Haemophilus parainfluenzae from respiratory and urogenital samples in Barcelona, Spain

European journal of clinical microbiology & infectious diseases, 2020-04, Vol.39 (4), p.703-710

2020

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of Drug Interactions Between Antiretrovirals and Co-Medications, Including Over-the-Counter Drugs: A Real-World Study

Infectious diseases and therapy, 2024-03, Vol.13 (3), p.609-617

2024

Link zum Volltext

Verfügbarkeit prüfen

Comparative Analysis of Primary and Monovalent Booster SARS-CoV-2 Vaccination Coverage in Adults with and without HIV in Catalonia, Spain

Vaccines (Basel), 2023-12, Vol.12 (1), p.44

2023

Link zum Volltext

Verfügbarkeit prüfen

Vaccination coverage for people living with HIV: a key intervention that should be improved

Enfermedades infecciosas y microbiologia clinica (English ed.), 2023-03, Vol.41 (3), p.141-143

2023

Link zum Volltext

Verfügbarkeit prüfen

SARS-CoV-2 Vaccination Coverage and Factors Associated with Low Uptake in a Cohort of People Living with HIV

Microorganisms (Basel), 2022-08, Vol.10 (8), p.1666

2022

Link zum Volltext

Verfügbarkeit prüfen

Tenofovir alafenamide, emtricitabine, elvitegravir, and cobicistat combination therapy for the treatment of HIV

Expert review of anti-infective therapy, 2017-03, Vol.15 (3), p.195-209

2017

Link zum Volltext

Verfügbarkeit prüfen

Vaccination coverage for people living with HIV: a key intervention that should be improved

Enfermedades infecciosas y microbiologia clinica (English ed.), 2023-03, Vol.41 (3), p.141-143

2023

Link zum Volltext

Verfügbarkeit prüfen

Lack of benefit with omega-3 fatty acid supplementation in HIV patients: A randomized pilot study

HIV research & clinical practice, 2019-05, Vol.20 (3), p.99-105

2019

Link zum Volltext

Verfügbarkeit prüfen

Liver Stiffness-Based Strategies Predict Absence of Variceal Bleeding in Cirrhotic Hepatitis C Virus-Infected Patients With and Without Human Immunodeficiency Virus Coinfection After Sustained Virological Response

Clinical infectious diseases, 2021-03, Vol.72 (5), p.e96-e102

2021

Link zum Volltext

Verfügbarkeit prüfen

Dual antiretroviral therapy: finding a place in the battle

The lancet HIV, 2016-08, Vol.3 (8), p.e335-e336

2016

Link zum Volltext

Verfügbarkeit prüfen

Changes in Body Fat Distribution in Antiretroviral-Naive HIV-Positive Individuals Initiating Current ART Regimens

The journal of clinical endocrinology and metabolism, 2019-03, Vol.104 (3), p.900-905

2019

Link zum Volltext

Verfügbarkeit prüfen

Total and Unbound Bictegravir Concentrations and Viral Suppression in Cerebrospinal Fluid of Human Immunodeficiency Virus-Infected Patients (Spanish HIV/AIDS Research Network, PreEC/RIS 56)

The Journal of infectious diseases, 2020-04, Vol.221 (9), p.1425-1428

2020

Link zum Volltext

Verfügbarkeit prüfen

Decay of HIV RNA in Seminal Plasma and Rectal Fluid in Treatment-Naive Adults Starting Antiretroviral Therapy With Dolutegravir Plus Lamivudine or Bictegravir/Emtricitabine/Tenofovir Alafenamide

The Journal of infectious diseases, 2023-10, Vol.228 (7), p.919-925

2023

Link zum Volltext

Verfügbarkeit prüfen

Validation of an LC-MS/MS assay for the simultaneous determination of bictegravir, doravirine, and raltegravir in human plasma

Journal of pharmaceutical and biomedical analysis, 2022-10, Vol.220, p.115010-115010, Article 115010

2022

Link zum Volltext

Verfügbarkeit prüfen

Development and validation of equilibrium dialysis UHPLC-MS/MS measurement procedures for total and unbound concentrations of bictegravir, dolutegravir, darunavir and doravirine in human plasma. Application to patients with HIV

Clinica chimica acta, 2024-01, Vol.552, p.117678-117678, Article 117678

2024

Link zum Volltext

Verfügbarkeit prüfen

Doravirine Concentrations and Human Immunodeficiency Virus Type 1 RNA in the Genital Fluids of Virologically Suppressed Adults Switching to Doravirine Plus Emtricitabine/Tenofovir Alafenamide

Clinical infectious diseases, 2022-11, Vol.75 (11), p.2012-2015

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical and pathological features of Kaposi sarcoma herpesvirus-associated inflammatory cytokine syndrome

AIDS (London), 2020-11, Vol.34 (14), p.2097-2101

2020

Link zum Volltext

Verfügbarkeit prüfen

Total and Unbound Doravirine Concentrations and Viral Suppression in CSF

Clinical infectious diseases, 2022-05, Vol.74 (10), p.1855-1858

2022

Link zum Volltext

Verfügbarkeit prüfen

Removal of doravirine by haemodialysis in people living with HIV with end-stage renal disease

Journal of antimicrobial chemotherapy, 2022-06, Vol.77 (7), p.1989-1991

2022

Link zum Volltext

Verfügbarkeit prüfen

Effectiveness of Once/Day Dolutegravir Plus Boosted Darunavir as a Switch Strategy in Heavily Treated Patients with Human Immunodeficiency Virus

Pharmacotherapy, 2019-04, Vol.39 (4), p.501-507

2019

Link zum Volltext

Verfügbarkeit prüfen

Major cardiovascular events after COVID-19 in people with HIV

Clinical microbiology and infection, 2024-05, Vol.30 (5), p.674-681

2024

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 101

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(97)
Mit Volltextzugriff
(91)

Publikationsform

Artikel
(99)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(78)
Life Sciences & Biomedicine
(75)
Infectious Diseases
(64)
Humans
(56)
Hiv Infections - Drug Therapy
(40)
Hiv
(37)
Microbiology
(37)
Adult
(36)
Male
(35)
Female
(34)
Human Immunodeficiency Virus
(31)
Pharmacology & Pharmacy
(29)
Immunology
(28)
Middle Aged
(24)
Treatment Outcome
(19)
Anti-Hiv Agents - Therapeutic Use
(17)
Antiretroviral Drugs
(16)
Virology
(16)
Hiv Infections - Virology
(15)
Anti-Hiv Agents - Administration & Dosage
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Emergence of multidrug resistance among Haemophilus parainfluenzae from respiratory and urogenital samples in Barcelona, Spain

High quality of life, treatment tolerability, safety and efficacy in HIV patients switching from triple therapy to lopinavir/ritonavir monotherapy: A randomized clinical trial

Outcomes of Drug Interactions Between Antiretrovirals and Co-Medications, Including Over-the-Counter Drugs: A Real-World Study

Comparative Analysis of Primary and Monovalent Booster SARS-CoV-2 Vaccination Coverage in Adults with and without HIV in Catalonia, Spain

Vaccination coverage for people living with HIV: a key intervention that should be improved

SARS-CoV-2 Vaccination Coverage and Factors Associated with Low Uptake in a Cohort of People Living with HIV

Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study

Correction: Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study

Tenofovir alafenamide, emtricitabine, elvitegravir, and cobicistat combination therapy for the treatment of HIV

Vaccination coverage for people living with HIV: a key intervention that should be improved

Lack of benefit with omega-3 fatty acid supplementation in HIV patients: A randomized pilot study

Liver Stiffness-Based Strategies Predict Absence of Variceal Bleeding in Cirrhotic Hepatitis C Virus-Infected Patients With and Without Human Immunodeficiency Virus Coinfection After Sustained Virological Response

Dual antiretroviral therapy: finding a place in the battle

Changes in Body Fat Distribution in Antiretroviral-Naive HIV-Positive Individuals Initiating Current ART Regimens

Total and Unbound Bictegravir Concentrations and Viral Suppression in Cerebrospinal Fluid of Human Immunodeficiency Virus-Infected Patients (Spanish HIV/AIDS Research Network, PreEC/RIS 56)

Decay of HIV RNA in Seminal Plasma and Rectal Fluid in Treatment-Naive Adults Starting Antiretroviral Therapy With Dolutegravir Plus Lamivudine or Bictegravir/Emtricitabine/Tenofovir Alafenamide

Validation of an LC-MS/MS assay for the simultaneous determination of bictegravir, doravirine, and raltegravir in human plasma

Development and validation of equilibrium dialysis UHPLC-MS/MS measurement procedures for total and unbound concentrations of bictegravir, dolutegravir, darunavir and doravirine in human plasma. Application to patients with HIV

Doravirine Concentrations and Human Immunodeficiency Virus Type 1 RNA in the Genital Fluids of Virologically Suppressed Adults Switching to Doravirine Plus Emtricitabine/Tenofovir Alafenamide

Clinical and pathological features of Kaposi sarcoma herpesvirus-associated inflammatory cytokine syndrome

Total and Unbound Doravirine Concentrations and Viral Suppression in CSF

Removal of doravirine by haemodialysis in people living with HIV with end-stage renal disease

Effectiveness of Once/Day Dolutegravir Plus Boosted Darunavir as a Switch Strategy in Heavily Treated Patients with Human Immunodeficiency Virus

Dynamics of the Decay of Human Immunodeficiency Virus (HIV) RNA and Distribution of Bictegravir in the Genital Tract and Rectum in Antiretroviral-naive Adults Living With HIV–1 Treated With Bictegravir/Emtricitabine/Tenofovir Alafenamide (Spanish HIV/AIDS Research Network, PreEC/RIS 58)

Major cardiovascular events after COVID-19 in people with HIV

Suchergebnisse filtern